Datamonitor's Novo Nordisk A/S - SWOT Analysis company profile is the essential source for top-level company data and information. Novo Nordisk A/S - SWOT Analysis examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Novo Nordisk is a healthcare company engaged in the manufacturing and marketing of diabetes products. It also offers product in the therapeutic areas of haemostasis management, growth hormone therapy and hormone replacement therapy. The company primarily operates in Europe, North America and Japan. It is headquartered in Bagsvaerd, Denmark and employs about 27,900 people. The company recorded revenues of DKK45,553 million ($8,989.4 million) during the financial year (FY) ended December 2008, an increase of 8.9% over FY2007. The increase in revenues was due to higher sales of diabetes products and biopharmaceuticals. The operating profit of the company was DKK12,373 million ($2,441.7 million) during FY2008, an increase of 38.4% over FY2007. The net profit of the company was DKK9,645 million ($1,903.3 million) in FY2008, an increase of 13.2% over FY2007.Scope of the Report- Provides all the crucial information on Novo Nordisk A/S required for business and competitor intelligence needs- Contains a study of the major internal and external factors affecting Novo Nordisk A/S in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Novo Nordisk A/S-Data is supplemented with details on Novo Nordisk A/S history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Novo Nordisk A/SReasons to Purchase- Support sales activities by understanding your customers' businesses better- Qualify prospective partners and suppliers- Keep fully up to date on your competitors' business structure, strategy and prospects- Obtain the most up to date company information available
Malad Call Girl in Services 9892124323 | ₹,4500 With Room Free Delivery
Novo Nordisk A/S - SWOT analysis
1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Novo Nordisk A/S - SWOT analysis
Published on November 2009
Report Summary
Datamonitor's Novo Nordisk A/S - SWOT Analysis company profile is the essential source for top-level company data and information.
Novo Nordisk A/S - SWOT Analysis examines the company's key business structure and operations, history and products, and
provides summary analysis of its key revenue lines and strategy.
Novo Nordisk is a healthcare company engaged in the manufacturing and marketing of diabetes products. It also offers product in the
therapeutic areas of haemostasis management, growth hormone therapy and hormone replacement therapy. The company primarily
operates in Europe, North America and Japan. It is headquartered in Bagsvaerd, Denmark and employs about 27,900 people. The
company recorded revenues of DKK45,553 million ($8,989.4 million) during the financial year (FY) ended December 2008, an
increase of 8.9% over FY2007. The increase in revenues was due to higher sales of diabetes products and biopharmaceuticals. The
operating profit of the company was DKK12,373 million ($2,441.7 million) during FY2008, an increase of 38.4% over FY2007. The net
profit of the company was DKK9,645 million ($1,903.3 million) in FY2008, an increase of 13.2% over FY2007.
Scope of the Report
- Provides all the crucial information on Novo Nordisk A/S required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Novo Nordisk A/S in the form of a SWOT analysis as well as a
breakdown and examination of leading product revenue streams of Novo Nordisk A/S
-Data is supplemented with details on Novo Nordisk A/S history, key executives, business description, locations and subsidiaries as
well as a list of products and services and the latest available statement from Novo Nordisk A/S
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available
Table of Content
Table of Contents:
This product typically includes the following sections:
SWOT COMPANY PROFILE: Novo Nordisk A/S
Key Facts: Novo Nordisk A/S
Company Overview: Novo Nordisk A/S
Business Description: Novo Nordisk A/S
Company History: Novo Nordisk A/S
Key Employees: Novo Nordisk A/S
Novo Nordisk A/S - SWOT analysis Page 1/4
2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Key Employee Biographies: Novo Nordisk A/S
Products & Services Listing: Novo Nordisk A/S
Products & Services Analysis: Novo Nordisk A/S
SWOT analysis: Novo Nordisk A/S
*Strengths: Novo Nordisk A/S
*Weaknesses: Novo Nordisk A/S
*Opportunities: Novo Nordisk A/S
*Threats: Novo Nordisk A/S
Company View: Novo Nordisk A/S
Top Competitors: Novo Nordisk A/S
Location and Subsidiary: Novo Nordisk A/S
*Head Office: Novo Nordisk A/S
*Other Locations and Subsidiaries: Novo Nordisk A/S
Novo Nordisk A/S - SWOT analysis Page 2/4
3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Novo Nordisk A/S - SWOT analysis
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 125.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Novo Nordisk A/S - SWOT analysis Page 3/4
4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Novo Nordisk A/S - SWOT analysis Page 4/4